The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.

Pfizer rises after a study found that the company's new mRNA flu vaccine outperforms traditional shots against predominant strains.

An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

US pharma giant Pfizer has provided a reminder of the merits of mRNA-based vaccines as health leaders in the USA continue to question their safety.

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Explore and inspect fantastical environments in The Bureau of Fantastical & Arcane Affairs, a first-person comedy narrative sandbox game. Whether you decide to fix what's wrong with the fantasy world ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

A new mRNA-based flu vaccine from Pfizer has shown greater effectiveness than the standard flu shot in a large Phase 3 trial, according to results published in the New England Journal of Medicine. The ...

Google has appointed Farhan Qureshi as regional director for Pakistan, the Philippines, Thailand and Frontier Markets, strengthening its leadership across fast-growing Asian regions.

USA: A major phase 3 clinical trial has provided promising evidence that a modified mRNA (modRNA) influenza vaccine may offer ...

For decades, the flu virus in the shots you’re offered every fall has been grown in chicken eggs. Now, scientists are trying ...